The European Medicines Agency has started a second rolling review of a COVID-19 vaccine – this time for BNT162b2, which BioNTech is developing in collaboration with Pfizer.
The EMA said on 6 October that its human medicines committee (the CHMP) has started evaluating the first batch of...






